Search clinical trials for: ICA

Total 2510 results

Integra LifeSciences Corporation
Icahn School of Medicine at Mount Sinai; Oculus Imaging LLC

Recruiting

The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation (MIRROR)

Supratentorial Hemorrhage

United States
DBV Technologies

Recruiting

Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children (APTITUDE)

Cow's Milk Allergy

Italy, United States, Lithuania, Canada
QuantumLeap Healthcare Collaborative
M.D. Anderson Cancer Center; University of Colorado, Denver; University of Pennsylvania and other collaborators

Recruiting

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients (I-SPY_COVID)

COVID-19

United States
Kartos Therapeutics, Inc.

Recruiting

An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib

Myelofibrosis

United States, France, Australia, Spain, Germany, Bulgaria, Israel, Italy, Poland
Luzerner Kantonsspital

Recruiting

Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring

Intraocular Pressure

Switzerland
Eisai Inc.
National Institute on Aging (NIA); Biogen; Alzheimer's Clinical Trials Consortium

Recruiting

AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

Preclinical Alzheimer's Disease | Early Preclinical Alzheimer's Disease

United States, Singapore, Canada, Spain, Australia, Japan, United Kingdom, Sweden, Netherlands
Sanofi

Recruiting

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) (PERSEUS)

Primary Progressive Multiple Sclerosis

Spain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more
Newcastle University
Assistance Publique - Hôpitaux de Paris; Medical University of Vienna; University... and other collaborators

Recruiting

The European NAFLD Registry

Cardiovascular Diseases | Hypertension | Obesity | Hepatocellular Carcinoma | Type 2 Diabetes | NAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Dyslipidaemia | NASH | Steatosis of Liver | Other Associated Comorbidities

Netherlands, Germany, United Kingdom, Finland, Belgium, Greece, Italy, Sweden, Portugal, Spain, France, Switzerland
Celgene

Recruiting

Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms

United States
Icahn School of Medicine at Mount Sinai
National Center for Complementary and Integrative Health (NCCIH)

Recruiting

Metabolism of Bioactive Dietary Polyphenol Preparation (BDPP)

Healthy Control

United States
Cabaletta Bio

Recruiting

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

Pemphigus Vulgaris

United States
Fractyl Health Inc.

Recruiting

Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1)

Type 2 Diabetes

United States, Ireland, United Kingdom, Belgium, Italy, Netherlands, Switzerland, Spain, France
Icahn School of Medicine at Mount Sinai

Recruiting

Abdominal Binder and Steps Trial (ABS)

Post-operative Milestones

United States
Martin Dichgans
University Hospital Muenster; Universitätsklinikum Hamburg-Eppendorf

Recruiting

Inflammatory faCtors AfteR acUte Ischemic Stroke (ICARUS)

Ischemic Stroke

Germany
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Recruiting

Self-Control in Bulimia Nervosa

Bulimia Nervosa

United States
Hoffmann-La Roche

Recruiting

A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Diffuse Large B-cell Lymphoma

Korea, Republic of, United States, China, Germany, Poland, Spain, Taiwan, United Kingdom, Australia, France, Belgium, Switzerland, Denmark, Puerto Rico
Coherus Biosciences, Inc.
Merck Sharp & Dohme LLC

Recruiting

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Clear Cell Renal Cell Carcinoma | Hepatocellular Carcinoma | Advanced Solid Tumor | Non-small Cell Lung Cancer

Korea, Republic of, United States, Singapore
Icahn School of Medicine at Mount Sinai
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV (EVA)

HIV | Non-HIV | Vagus Nerve Dysfunction

United States
Stanford University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Patient Reported Outcomes for Acute Asthma Care Treatment (PROAACT)

Asthma

United States
Icahn School of Medicine at Mount Sinai
Northwestern University; The Cleveland Clinic; University of California, Davis; RxHealt...

Recruiting

Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes

Inflammatory Bowel Disease (IBD)

United States
Albireo

Recruiting

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

Biliary Atresia

Netherlands, United States, Spain, Italy, Taiwan, Korea, Republic of, France, Germany, United Kingdom, Canada, Belgium, China, Australia, Poland, Turkey, Malaysia, New Zealand, Hungary, Israel
Sir Mortimer B. Davis - Jewish General Hospital
Icad, Inc.

Recruiting

Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy (Whistle)

Rectal Cancer | Inoperable Disease | Comorbidities and Coexisting Conditions | Brachytherapy

Canada
University of Washington
Johns Hopkins University; National Institute of Diabetes and Digestive and... and other collaborators

Recruiting

Kidney Precision Medicine Project (KPMP)

Chronic Kidney Diseases | Acute Renal Failure | Acute Renal Injury | Acute Kidney Failure | Chronic Renal Insufficiency | Kidney Failure, Acute | Renal Insufficiency, Acute | Acute Renal Insufficiency | Acute Kidney Insufficiency | Renal Failure, Acute | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney... and other conditions

United States
The Lymphoma Academic Research Organisation
Novartis; Gilead Sciences

Recruiting

French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)

Hematopathology Eligible or CAR-t Cell Treatment

France
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Stage II Kidney Wilms Tumor | Stage III Kidney Wilms Tumor | Stage IV Kidney Wilms Tumor | Recurrent Kidney Wilms Tumor | Anaplastic Kidney Wilms Tumor

United States, Canada, Puerto Rico, Australia, New Zealand, Saudi Arabia
Icahn School of Medicine at Mount Sinai

Recruiting

A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation

Stomach Cancer | Gastric Cancer

United States
Icahn School of Medicine at Mount Sinai

Recruiting

Use of ReDS Technology in Patients With Acute Heart Failure

Heart Failure | Lung Congestion

United States
Eisai Inc.
Bristol-Myers Squibb

Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

Solid Tumor

United States, Spain, United Kingdom, France
Vyriad, Inc.
Regeneron Pharmaceuticals

Recruiting

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Melanoma | Head and Neck Squamous Cell Carcinoma | Colo-rectal Cancer

United States, Brazil
University of California, San Diego
Icahn School of Medicine at Mount Sinai; Bayer Healthcare Pharmaceuticals,...

Recruiting

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

Liver Cancer | Liver Carcinoma | Liver Cirrhoses

United States
Icahn School of Medicine at Mount Sinai

Recruiting

Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma (HNSCC)

United States
Icahn School of Medicine at Mount Sinai

Recruiting

Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy

Fibroid Uterus

United States
Astex Pharmaceuticals, Inc.

Recruiting

A Study of ASTX030 (Cedazuridine in Combination With Azacitidine) in MDS, CMML, or AML

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelocytic Leukemia | Myelodysplastic Syndrome/Neoplasm

United States, Canada
New York State Psychiatric Institute
Icahn School of Medicine at Mount Sinai; Stanford University

Recruiting

Tianeptine for Treatment Resistant Depression

Treatment Resistant Depression

United States
Barcelona Institute for Global Health
Bill and Melinda Gates Foundation; University of Sierra Leone; La Caixa Foundation and other collaborators

Recruiting

Improving Care Through Azithromycin Research for Infants in Africa (ICARIA)

Child Mortality

Sierra Leone
Yale University
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Recruiting

Emergency Department-Initiated Buprenorphine Validation Network Trial

Opioid-use Disorder

United States
Icahn School of Medicine at Mount Sinai
Mayo Clinic; Baylor College of Medicine; Children's Hospital of Philadelphia; University... and other collaborators

Recruiting

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Congenital Disorders of Glycosylation

United States
Amgen

Recruiting

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Advanced Solid Tumors | Kirsten Rat Sarcoma (KRAS) pG12C Mutation

United States, Italy, Taiwan, Spain, United Kingdom, Australia, Austria, Germany, Belgium, Japan, Netherlands, Korea, Republic of, Canada
Hookipa Biotech GmbH

Recruiting

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

HPV-Related Squamous Cell Carcinoma

United States, Spain, Netherlands
Sumitomo Pharma America, Inc.

Recruiting

A Study of Oral TP-3654 in Patients With Myelofibrosis

Myelofibrosis

United States, Belgium, France, Japan, Australia, Italy, United Kingdom
Jeffrey Newcorn
National Institute on Drug Abuse (NIDA)

Recruiting

Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder

Conduct Disorder | Substance Abuse | Attention Deficit Disorder With Hyperactivity

United States
Emory University
University of Calgary; Children's Hospital Medical Center, Cincinnati; Heidelberg... and other collaborators

Recruiting

Endovascular Therapy for Low NIHSS Ischemic Strokes (ENDOLOW)

Cerebral Ischemia

United States, Canada, Germany
iCell Gene Therapeutics
Peking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.

Recruiting

CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies

Refractory T-Cell Lymphoma | T Cell Lymphoma in Relapse

China
iCell Gene Therapeutics
Peking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.

Recruiting

BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma

Refractory Multiple Myeloma | Multiple Myeloma in Relapse | Plasmacytoid; Lymphoma

China
ModernaTX, Inc.

Recruiting

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

Propionic Acidemia

United States, Canada, United Kingdom
Wake Forest University Health Sciences
Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaborators

Recruiting

Molecular Transducers of Physical Activity Consortium (MoTrPAC) - Pediatric Protocol (MoTrPAC)

Physical Activity

United States
Dragonfly Therapeutics

Recruiting

Study of DF1001 in Patients With Advanced Solid Tumors

Solid Tumor, Adult

United States, Denmark, Netherlands, Belgium, France
Icahn School of Medicine at Mount Sinai

Recruiting

Real-time Biofeedback With 7-Tesla MRI for Treatment of Depression (Biofeedback)

Major Depressive Disorder

United States
Weill Medical College of Cornell University
Sunnybrook Health Sciences Centre; Columbia University; Duke University; Cedars-Sinai... and other collaborators

Recruiting

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women (ROMA:Women)

Heart Diseases | Coronary Artery Disease | Coronary Artery Bypass Grafting

United States, Austria, Israel, Canada, Korea, Republic of, Spain, Sweden, Croatia, Germany, United Kingdom, China, Poland, Italy, Brazil, Czechia, India, Japan, Netherlands, Portugal, Serbia, Singapore, Taiwan, Australia, North Macedonia and more
UNICANCER

Recruiting

Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients (Oligo-PRESTO)

Oligometastatic Hormone Sensitive Prostate Cancer

France, Martinique

Search clinical trials for: ICA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations